SPARC and Hepatic fibrosis: To uncover new protective mechanisms involved in the observed reduction in the degree of liver fibrosis observed in SPARC deficient mice, cDNA expression array analyses were performed comparing liver tissue samples obtained from SPARC−/− and SPARC+/+ mice after 10 weeks of TAA administration.